DAIHAN Scientific Co. Ltd (131220) — Capital Reinvestment Ratio
DAIHAN Scientific Co. Ltd (131220) has a Capital Reinvestment Ratio of 0.48x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩361.12 Million) in capital expenditures (₩174.87 Million). See DAIHAN Scientific Co. Ltd (131220) balance sheet quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
DAIHAN Scientific Co. Ltd Capital Reinvestment Ratio (2012–2024)
This chart tracks DAIHAN Scientific Co. Ltd's Capital Reinvestment Ratio across 12 annual periods. Check DAIHAN Scientific Co. Ltd (131220) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for DAIHAN Scientific Co. Ltd (2012–2024)
Year-by-year Capital Reinvestment Ratio for DAIHAN Scientific Co. Ltd from 2012 to 2024. For live market cap and broader valuation context, see DAIHAN Scientific Co. Ltd stock valuation.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.12x | ₩3.99 Billion | ₩494.10 Million | ▼ -8.0% |
| 2023 | 0.13x | ₩4.79 Billion | ₩645.76 Million | ▼ -80.0% |
| 2022 | 0.67x | ₩4.51 Billion | ₩3.04 Billion | ▼ -12.8% |
| 2021 | 0.77x | ₩4.13 Billion | ₩3.19 Billion | ▲ +317.8% |
| 2020 | 0.18x | ₩5.35 Billion | ₩988.48 Million | ▼ -52.0% |
| 2019 | 0.39x | ₩2.44 Billion | ₩939.56 Million | ▼ -14.5% |
| 2018 | 0.45x | ₩3.76 Billion | ₩1.69 Billion | ▲ +199.4% |
| 2017 | 0.15x | ₩4.58 Billion | ₩689.55 Million | ▲ +4.2% |
| 2016 | 0.14x | ₩4.12 Billion | ₩595.73 Million | ▼ -88.3% |
| 2015 | 1.23x | ₩898.12 Million | ₩1.11 Billion | ▲ +644.7% |
| 2014 | 0.17x | ₩2.59 Billion | ₩429.31 Million | ▼ -89.7% |
| 2012 | 1.61x | ₩565.94 Million | ₩909.46 Million | — |